Clinical Characteristics and Mortality Predictors of Group B Streptococcus Bacteremia in Adults: A Multicenter Retrospective Cohort Study in Japan, 2015-2024.
10 affiliations
- 1Department of Infectious Diseases, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
- 2Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
- 3Department of Bacteriology, Okayama University, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
- 4Emergency and Critical Care Center, Kurashiki Central Hospital, Kurashiki, Okayama, Japan.
- 5Department of Emergency and Critical Care Medicine, Shimane Prefectural Central Hospital, Izumo, Shimane, Japan.
- 6Department of Pharmacy, Tsuyama Chuo Hospital, Tsuyama, Okayama, Japan.
- 7Department of Infectious Diseases and General Internal Medicine, Tottori Prefectural Central Hospital, Tottori, Japan.
- 8Department of Pharmacy, Japanese Red Cross Society Himeji Hospital, Himeji, Hyogo, Japan.
- 9Department of General Internal Medicine, Masuda Red-Cross Hospital, Masuda, Shimane, Japan.
- 10Department of General Medicine, Okuizumo Hospital, Okuizumo, Shimane, Japan.
Abstract
Background
Invasive group B Streptococcus (GBS) infection in nonpregnant adults is increasing, particularly among older adults and those with underlying comorbidities. However, multicenter data on prognostic factors for adult GBS bacteremia in Japan remain limited.Methods
We conducted a multicenter retrospective observational cohort study of adults with GBS bacteremia at 7 hospitals in western Japan between 2015 and 2024. Variables analyzed included clinical characteristics, infection sites, microbiological characteristics, and antimicrobial susceptibility profiles. Univariable and multivariable logistic regression analyses were performed to identify factors associated with 30-day mortality.Results
A total of 442 patients were included. Median age [interquartile range] was 75 [64-84] years, and 83.0% had at least 1 comorbidity. The overall 30-day all-cause mortality for GBS bacteremia was 9.3% (41/442), which rose to 39.3% (11/28) among patients with streptococcal toxic shock syndrome (STSS). In multivariable analysis, STSS was the strongest predictor of death (adjusted odds ratio [aOR], 9.16; 95% confidence interval [CI], 3.28-25.58), followed by immunosuppressive therapy (aOR, 4.62; 95% CI, 1.66-12.86), cirrhosis (aOR, 3.40; 95% CI, 1.23-9.40), respiratory infection (aOR, 3.30; 95% CI, 1.08-10.06), advanced renal dysfunction (aOR, 2.66; 95% CI, 1.09-6.52), and polymicrobial bacteremia (aOR, 2.40; 95% CI, 1.03-5.57), whereas skin and soft tissue infection was associated with lower mortality (aOR, 0.07; 95% CI, 0.01-0.53).Conclusions
Adult GBS bacteremia carries a high burden of short-term mortality, with a wide variety of clinical presentations, necessitating prompt diagnostic and therapeutic intervention.
Related
- Predictors and prescribing patterns of definite anticholinergic medication use among community-dwelling older adults in Saudi Arabia: a retrospective multicenter cross-sectional study
- Clinical Characteristics of Respiratory Syncytial Virus Infection in Korean Children: An 11-Year Multicenter Retrospective Study.
- Patient characteristics, fracture distribution and management patterns of incomplete thoracolumbar burst fractures: Results from a retrospective multicenter cohort of 982 patients.
- Clinical Characteristics of Patients Presenting with Moderate-to-Severe Atopic Dermatitis and Concomitant Inflammatory Bowel Diseases: a Multicenter Retrospective Study.
- Clinical and Microbiological Characteristics of Patients with Desulfovibrio spp. Bacteremia in a Japanese Tertiary Hospital: A Case Series
BibTeX
@article{oguni2026clinical,
title = {{Clinical Characteristics and Mortality Predictors of Group B Streptococcus Bacteremia in Adults: A Multicenter Retrospective Cohort Study in Japan, 2015-2024.}},
author = {Kohei Oguni and Hidemasa Akazawa and Shinnosuke Fukushima and Yasuhiro Suzuki and Katsuki Kanai and Yuto Haruki and Kengo Mukuda and Hidemaru Matsumoto and Tatsuya Fujihara and Hideharu Hagiya},
journal = {Open forum infectious diseases},
year = {2026},
month = oct,
doi = {10.1093/ofid/ofag665},
url = {https://europepmc.org/article/MED/42909912},
note = {CC BY},
}
RIS
TY - JOUR
TI - Clinical Characteristics and Mortality Predictors of Group B Streptococcus Bacteremia in Adults: A Multicenter Retrospective Cohort Study in Japan, 2015-2024.
AU - Kohei Oguni
AU - Hidemasa Akazawa
AU - Shinnosuke Fukushima
AU - Yasuhiro Suzuki
AU - Katsuki Kanai
AU - Yuto Haruki
AU - Kengo Mukuda
AU - Hidemaru Matsumoto
AU - Tatsuya Fujihara
AU - Hideharu Hagiya
PY - 2026
DA - 2026/10/09
JO - Open forum infectious diseases
DO - 10.1093/ofid/ofag665
UR - https://europepmc.org/article/MED/42909912
AB - Background Invasive group B Streptococcus (GBS) infection in nonpregnant adults is increasing, particularly among older adults and those with underlying comorbidities. However, multicenter data on prognostic factors for adult GBS bacteremia in Japan remain limited.Methods We conducted a multicenter retrospective observational cohort study of adults with GBS bacteremia at 7 hospitals in western Japan between 2015 and 2024. Variables analyzed included clinical characteristics, infection sites, microbiological characteristics, and antimicrobial susceptibility profiles. Univariable and multivariable logistic regression analyses were performed to identify factors associated with 30-day mortality.Results A total of 442 patients were included. Median age [interquartile range] was 75 [64-84] years, and 83.0% had at least 1 comorbidity. The overall 30-day all-cause mortality for GBS bacteremia was 9.3% (41/442), which rose to 39.3% (11/28) among patients with streptococcal toxic shock syndrome (STSS). In multivariable analysis, STSS was the strongest predictor of death (adjusted odds ratio [aOR], 9.16; 95% confidence interval [CI], 3.28-25.58), followed by immunosuppressive therapy (aOR, 4.62; 95% CI, 1.66-12.86), cirrhosis (aOR, 3.40; 95% CI, 1.23-9.40), respiratory infection (aOR, 3.30; 95% CI, 1.08-10.06), advanced renal dysfunction (aOR, 2.66; 95% CI, 1.09-6.52), and polymicrobial bacteremia (aOR, 2.40; 95% CI, 1.03-5.57), whereas skin and soft tissue infection was associated with lower mortality (aOR, 0.07; 95% CI, 0.01-0.53).Conclusions Adult GBS bacteremia carries a high burden of short-term mortality, with a wide variety of clinical presentations, necessitating prompt diagnostic and therapeutic intervention.
SN - 2328-8957
ER -